FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/098364 [Registered on: 03/12/2025] Trial Registered Prospectively
Last Modified On: 02/12/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of Dexmedetomidine and dexamethasone in supraclavicular block for upper arm surgery 
Scientific Title of Study   Comparison Between Dexamethasone And Dexmedetomidine As A Perineural Adjuvant In Supraclavicular Brachial Plexus Block 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Neha Kumari 
Designation  Postgraduate Resident 
Affiliation  Peoples College Of Medical Sciences Bhopal 
Address  Room no 1 1st floor Peoples Hospital Bhanpur Ayodhya Bypass Road Bhopal Madhya Pradesh 462037

Bhopal
MADHYA PRADESH
462037
India 
Phone  9630557125  
Fax    
Email  Dr.nehayadav687@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Akanksha Agarwal 
Designation  Professor Department of Anaesthesiology 
Affiliation  Peoples College Of Medical Sciences and Research Centre Bhopal 
Address  Room no 1 Department of Anaesthesiology Poeples Hospital Bhanpur Bhopal

Bhopal
MADHYA PRADESH
462037
India 
Phone  8989147838  
Fax    
Email  akankshaagarwal2020@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Akanksha Agarwal 
Designation  Professor Department of Anaesthesiology 
Affiliation  Peoples College Of Medical Sciences and Research Centre Bhopal 
Address  Room no 1 Department of Anaesthesiology Poeples Hospital Bhanpur Bhopal

Bhopal
MADHYA PRADESH
462037
India 
Phone  8989147838  
Fax    
Email  akankshaagarwal2020@gmail.com  
 
Source of Monetary or Material Support  
Peoples Hospital Bhanpur Bhopal Madhya Pradesh India 462037 
 
Primary Sponsor  
Name  Peoples Hospital Bhanpur Bhopal 
Address  Ayodhya Bypass Road Bhopal Madhya Pradesh 462037 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Neha Kumari  Peoples Hospital  Room no 1 1st floor Department of Anaesthesiology PCMS and RC Bhanpur Bhopal
Bhopal
MADHYA PRADESH 
9630557125

Dr.nehayadav687@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Peoples College Of Medical Sciences And Research Centre By Pass Road Bhanpur Bhopal 462037 M P Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Dexemethasone  Patient will receive Injection Dexamethasone 4mg diluted with Normal Saline upto 5ml with Injection 0.5 percent bupivacaine hydrochloride 15ml with inj lignocaine with adrenaline 10ml 
Comparator Agent  Dexmedetomidine  Patient will receive Inj Dexmedetomidine 50 mcg diluted with Normal Saline upto 5ml with Injection 0.5 percent bupivacaine hydrochloride 15ml with injection lignocaine with adrenaline 10ml and observed for sensory and motor block effect for 30 minutes 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Weight 50-80 kilograms
ASA grade I and II
All patients scheduled for elective upper limb surgeries under supraclavicular brachial plexus block 
 
ExclusionCriteria 
Details  Patient refusal for consent
Age less than 18 years and more than 60 years
ASA grade III and IV
Patients with abnormal coagulation profile
Patients with local skin site infections
Patient allergic to study drugs
Pregnant and lactating mothers
Failure or inadaequate supraclavivular block patient will be excluded 
 
Method of Generating Random Sequence   Adaptive randomization, such as minimization 
Method of Concealment   Dates of Birth or day of the Week 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the effects of Dexmedetomidine and Dexamethasone as a perineural adjuvant to 0.5% Bupivacaine in supraclavicular brachial plexus block.  UPTO 6 hours 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the onset time and duration of sensory and motor blockade of Dexmedetomidine with 0.5% Bupivacaine for Supraclavicular brachial plexus block.
To assess the onset time and duration of sensory and motor blockade of Dexamethasone with 0.5% Bupivacaine for Supraclavicular brachial plexus block.
To observe time required for Rescue Analgesia in both the groups.
To compare the observations of the 2 groups.
 
upto 6 hours 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   13/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
As per the Allocated days for each groups, participants in Group A will receive Injection Dexmedetomidine 50mcg diluted with Normal Saline upto 5ml with Injection 0.5 percent bupivacaine hydrochloride 15ml with Injection lignocaine with adrenaline 10ml, 
and those in Group B will receive Injection Dexamethasone 4mg diluted with Normal Saline upto 5ml with Injection 0.5 percent bupivacaine hydrochloride 15ml with injection lignocaine with adrenaline 10ml.
Supraclavicular block will be given using landmark technique to the patients using drugs as per group under all aseptic precautions. Completion of injection will be considered as time 0
After completion of injection vital parameters will be noted.
Onset of sensory and motor blockade, duration of sensory and motor blockade will be assessed.
Sensory and motor blockade evaluation will be done every 2 min until complete sensory and motor block or till 30 min, whichever will be earlier. VAS scoring will be done post operatively every 1.5 hours till 6 hours.

 
Close